Basaglar is a prominent and effective brand of insulin developed and marketed by Eli Lilly and Company. A long-acting insulin called insulin glargine, Basaglar is primarily used in the treatment and management of both type 1 and type 2 diabetes. It primarily functions by reducing the level of glucose in the blood, helping patients to maintain an appropriate blood glucose level. Administered via injection under the skin, the dosages and timing are carefully monitored and prescribed according to the individual needs and responses of different patients.
The Basaglar KwikPen, a pre-filled injectable pen filled with insulin glargine, is especially favored for its convenience and accuracy. Moreover, Basaglar insulin pens are designed for single-patient use, which underscores the brand’s commitment to hygiene and safety. It is essential to note that Eli Lilly, the company behind Basaglar, is an esteemed name in the global pharmaceutical industry with a credible heritage and proven track record.
Patients looking to purchase Basaglar can easily access this medication from Canadian Insulin, a reliable and customer-centric online provider of pharmaceutical products. Offering competitive prices and convenient shipping options, Canadian Insulin provides an accessible and affordable way to secure this vital diabetes management medication.